Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion-Reference-Cited by-同舟云学术

Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion

Published:2020-08 Issue:4 Volume:9 Page:1452-1463
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Qiao Meng,Zhao Chao,Liu Qian,Wang Yan,Shi Jingyun,Ng Terry L.,Zhou Fei,Li Xuefei,Jiang Tao,Yang Shuo,Gao Guanghui,Xiong Anwen,Li Jiayu,Li Wei,Wu Fengying,Chen Xiaoxia,Su Chunxia,Ren Shengxiang,Zhou Caicun,Zhang Jun

Publisher

AME Publishing Company

Subject

Oncology

Link

http://tlcr.amegroups.com/article/download/42565/pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer;Frontiers in Oncology;2023-03-09

2. Targeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease;Translational Lung Cancer Research;2023-02

3. Current treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer;Expert Review of Anticancer Therapy;2022-12-29

4. Special issue “The advance of solid tumor research in China”: Real‐world clinical outcomes of alectinib for advanced nonsmall‐cell lung cancer patients with ALK fusion in China;International Journal of Cancer;2022-06-17

5. The impact of the ALK fusion variant on clinical outcomes in EML4-ALK patients with NSCLC: a systematic review and meta-analysis;Future Oncology;2022-01